期刊文献+

丁咯地尔联合厄贝沙坦治疗高血压糖尿病肾病疗效观察

下载PDF
导出
摘要 目的:探讨丁咯地尔联合厄贝沙坦治疗高血压糖尿病肾病的疗效。方法:将76例入选患者随机分为治疗组38例,对照组38例。在糖尿病治疗方案的基础上,治疗组用丁咯地尔0.1g+0.9%氯化钠注射液250ml静脉滴注,1次/d。14d为一疗程,观察4周,比较丁咯地尔联合厄贝沙坦对24h尿蛋白,BUN,SCr的影响。结果:治疗后2组都能降低患者尿白蛋白排泄率,但治疗组下降更加明显(P<0.01)。结论:丁咯地尔联合厄贝沙坦可明显降低早期糖尿病肾病患者24h尿蛋白。
出处 《医学信息(中旬刊)》 2011年第7期3093-3093,共1页 Medical Information Operations Sciences Fascicule
  • 相关文献

参考文献5

  • 1周建辉,陈香美,谢院生,吴杰,陆菊明,潘长玉.糖尿病肾病不同程度蛋白尿的相关因素分析及随访[J].中华肾脏病杂志,2005,21(5):251-255. 被引量:58
  • 2Tomas Berl Angiotensin - lonverting, enzyme inhibitors versus ATL receptor antagonistin cardiovascular ang rend protection:The case for ATI recoptor antagonist [ J ]. J. Am soc Nephrol,2004,15 : s71 - s76.
  • 3Junaid A, Rosenberg ME, Hostetter TH. Interaction of angioten - sinis and TGF- beta in the rat remnant Kidney [ J]. AM soc Neph -rol, 1997,8 ( 11 ) : 1732 - 1738.
  • 4Suzuki KATSUNORI, Souda SATOSHI, Ikarash I TOM 00, et al. Renopro- tective effects of Low - dose valsartam in type 2 dia - betic patients with diabetic nephropathy[ J]. Diabetes Researe -hand clinical practice,2003, 51 (2) :179 - 183.
  • 5DubourgA, SscamuffaRF. Enperimental overiew of a new vasoac -tive drug: butlomedilHel Angiology, 1981,32:663 - 675.

二级参考文献10

  • 1The 15th annual report of the United States Renal Data Systems. USRDS Coordinating Center. 2003.
  • 2Screening for type 2 diabetes. World Health Organization.2003
  • 3Rabkin R.Diabetic nephropathy. Clin Cornerstone, 2003, 5:1-11.
  • 4Bakris GL, Weir MR, Shanifar S, et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med, 2003,163: 1555-1565.
  • 5Sahay BK, Sahay RK. Hypertension in diabetes. J Indian Med Assoc, 2003,101: 12, 14,15, 44.
  • 6Lea JP,Nicholas SB. Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc, 2002, 94(8 Suppl): 7S-15S.
  • 7Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention,detection, evaluation, and treatment of high blood pressure:the JNC 7 report. JAMA, 2003, 289: 2560-2572.
  • 8Keane WF, Brenner BM, de Zeeuw D, et al. The risk of developing end-stage renal disease in patients with type 2diabetes and nephropathy: the RENAAL study. Kidney Iht,2003,63: 1499-1507.
  • 9Ruggenenti P, Perna A, Gherardi G, et al. Chronic proteinuric nephropathies:outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis, 2000, 35: 1155-1165.
  • 10Jude EB,Anderson SG, Cruickshank JK,et al. Natural history and prognostic factors of diabetic nephropathy in type 2diabetes. Q J Med, 2002, 95:371-377.

共引文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部